Cargando…
Clinical implication of cellular vaccine in glioma: current advances and future prospects
Gliomas, especially glioblastomas, represent one of the most aggressive and difficult-to-treat human brain tumors. In the last few decades, clinical immunotherapy has been developed and has provided exceptional achievements in checkpoint inhibitors and vaccines for cancer treatment. Immunization wit...
Autores principales: | Yan, Yuanliang, Zeng, Shuangshuang, Gong, Zhicheng, Xu, Zhijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685666/ https://www.ncbi.nlm.nih.gov/pubmed/33228738 http://dx.doi.org/10.1186/s13046-020-01778-6 |
Ejemplares similares
-
Identification of Aloperine as an anti-apoptotic Bcl2 protein inhibitor in glioma cells
por: Xu, Zhijie, et al.
Publicado: (2019) -
Exosome-based immunotherapy: a promising approach for cancer treatment
por: Xu, Zhijie, et al.
Publicado: (2020) -
Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance
por: Yan, Yuanliang, et al.
Publicado: (2020) -
A Machine Learning Algorithm for Predicting Therapeutic Response to
Anti-PD1
por: Yan, Yuanliang, et al.
Publicado: (2019) -
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2018)